Intraoperative tracing of meningioma with copper-64 DOTATATE
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a special imaging agent called [Cu64]DOTATATE that helps surgeons see meningioma tumors during surgery. It may make tumor removal more complete and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed meningioma that needs surgical removal after an MRI or previous biopsy.
- You are not pregnant or breastfeeding.
- Your surgery does not involve the nose, eyebrow, or other procedures where the detection tool cannot be used.
- You are not allergic to somatostatin analogs (a type of hormone-like drug).
- You can have an MRI scan safely.
- You have not had radiation therapy to the head before.
- You are not currently in another clinical trial for meningioma treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a special scan (Ga-68 DOTATATE PET combined with MRI) helps diagnose and guide treatment for certain brain tumors that have somatostatin receptors. It may help doctors better find tumor recurrence or remaining tumor after treatment.
This trial compares two similar PET scan medicines to see which one best helps identify meningiomas before surgery. If you’re getting pre-surgery testing, participating may help improve how doctors choose the best scan.
This trial uses a special PET scan (DOTATATE) to help plan radiation treatment for meningioma, a type of brain tumor. It aims to make radiation more precise, possibly reducing side effects.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
This Phase 1/2 study tests a targeted radioactive medicine (Lu-177-satoreotide) for meningiomas that keep coming back or keep growing. It works only if tumor imaging shows the tumor has the right “target” signal, and it aims to see how well it can control the disease and how safe it is.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.